$6.540
+0.164 (+2.51%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BOLT Prediction & Forecast by Similar Chart Analysis
Alphio's BOLT stock price prediction model matches the current Bolt Biotherapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.51 (-0.40%). The 1-week path is $6.45 (-1.36%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Bolt Biotherapeutics, Inc. Stock?
Bolt Biotherapeutics Inc is a good buy right now due to its current price of $6.54, which is significantly below the analyst price target of $22, indicating a potential upside of 236%. Additionally, the company's gross margin remains strong at 100%, suggesting that it can maintain profitability on its sales despite current losses. However, the main risk is its net income, which has been negative, with a reported loss of $7.72 million in Q2 2026, highlighting ongoing financial challenges.
BOLT stock price ended at $6.54 on Friday, after rising +2.51%
Bolt Biotherapeutics, Inc. (BOLT) last closed at $6.54, gaining +2.51%. These facts feed the 1-day and 1-week BOLT price prediction above.
Forecast Drivers
Bolt Biotherapeutics, Inc. (BOLT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches BOLT, ranked by similarity.
Seasonality analysis for BOLT
Historically the probability of a positive November return for BOLT is 11.36%. January offers the highest probability of a positive month at 44.26%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BOLT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $0.15 | $0.16 | $0.17 | -97.54% |
| Dec 2026 | $0.10 | $0.13 | $0.14 | -97.99% |
In 2026, Bolt Biotherapeutics, Inc. (BOLT) is projected to range from $0.10 to $0.17.
Bolt Biotherapeutics, Inc. 2026 monthly forecast
In Nov 2026, Bolt Biotherapeutics, Inc. is projected to average $0.16, with a low of $0.15 and high of $0.17.
In Dec 2026, Bolt Biotherapeutics, Inc. is projected to average $0.13, with a low of $0.10 and high of $0.14.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.